Sign in Create account

Syngene International Limited

Healthcare · Healthcare Services

NSE: SYNGENE BSE: 539268
₹365.30
▼ -1.90 (-0.52%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
75/100
Strong
Valuation
30/100
Expensive
Momentum
11/100
Bearish

QVM read Quality, pricey and fading Quality Strong, Valuation Expensive, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹14,746 Cr
PE (TTM)
64.2
Industry median 50.2 (44 companies)
Price to Book
3.0
PEG (TTM)
-1.3
Institutions holding %
39.84%
FII + DII, latest filed period
Piotroski Score
4
Relative return vs Nifty50, qtr %
-5.0
Relative return vs Sector, qtr %
-12.6
Free Cash Flow
₹571 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
-102.72%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
-34.86%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
-4.60%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
-15.02%
as of March 31, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
-17.05%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
1.38
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
13.44
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
15.44%
as of March 31, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
-0.89%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
9.89%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
4.49%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
8.35%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
6.54%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 7 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 4)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (6.5%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

3 of 4 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • No Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Fair Value Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.5%
Low 363.1000 · High 373.3000
1W return
-4.3%
Low 363.1000 · High 384.9000
1M return
-8.8%
Low 360.4000 · High 403.9500
52W return
-42.2%
Low 360.4000 · High 678.9500
Lifetime High ₹947.8000 (Dec. 2, 2024)
Lifetime Low ₹222.7000 (March 23, 2020)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
371.6
10D
375.7
20D
381.8
50D
395.4
100D
417.0
200D
457.4

Delivery and volume

Day avg. delivery
54.3%
Week avg. delivery
53.4%
Month avg. delivery
56.3%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

367.23
Pivot
First resistance371.37
Second resistance377.43
Third resistance381.57
First support361.17
Second support357.03
Third support350.97
Day RSI33.3
Day MFI46.7
Day MACD-7.88
Day MACD signal-7.08

Beta

1M0.54
3M0.76
1Y0.81
3Y0.74

Price change analysis

↓ -8.8%
Over 1 Month
LowHigh
360.40403.95
↓ -15.4%
Over 3 Months
LowHigh
360.40449.95
↓ -7.8%
Over 6 Months
LowHigh
360.40518.55
↓ -42.2%
Over 1 Year
LowHigh
360.40678.95
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 64.2 (own history: 51.4–79.0)
Fair Value Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹663 Cr
Net profit (June 30, 2026)
₹-2 Cr
Basic EPS (June 30, 2026)
₹-0.0500

Ranks #11 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter52.59%
  • Mutual funds25.78%
  • FII/FPI11.82%
  • Other DII2.24%
  • Public7.14%

Largest holders

NameCategoryShares %Shares
BIOCON LIMITEDPromoter52.3200%211185608
NIPPON LIFE INDIA TRUSTEE LTD- A/C NIPPON INDIA FOPublic7.7300%31185889
ICICI PRUDENTIAL NIFTY SMALLCAP 250 ETFPublic5.3000%21383751
DSP NIFTY SMALLCAP 250 INDEX FUNDPublic4.6100%18592785
GOVERNMENT OF SINGAPOREPublic2.1300%8606745

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings decreased from 52.68% to 52.59% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 13.90% to 11.82% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 24.18% to 25.78% in Jun 2026 qtr

39 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 1432 insider trades, 19 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
27 Dec 2024 ANJAN CHAKRABARTI Employee / designated person Sell 0 ₹0
23 Dec 2024 ANJAN CHAKRABARTI Employee / designated person Sell 0 ₹0
23 Dec 2024 ANJAN CHAKRABARTI Employee / designated person Buy 0 ₹0
11 Dec 2024 Biocon Limited Promoter Sell 0 ₹0
28 Nov 2024 Mayank Verma Employee / designated person Sell 0 ₹0
28 Nov 2024 DEEPAK VENKATRAMAN Employee / designated person Sell 0 ₹0
28 Nov 2024 DEEPAK VENKATRAMAN Employee / designated person Sell 0 ₹0
18 Nov 2024 ALOK MEHROTRA Employee / designated person Sell 0 ₹0
18 Nov 2024 ALOK MEHROTRA Employee / designated person Buy 0 ₹0
11 Nov 2024 SIBAJI BISWAS Key managerial personnel Sell 0 ₹0

All insider and SAST disclosures →

Deals (Bulk & Block)

All 105 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
30 Apr 2026 MICROCURVES TRADING PRIVATE LIMITED Bulk Buy 2,766,287 481.9000 NSE
30 Apr 2026 MICROCURVES TRADING PRIVATE LIMITED Bulk Sell 2,766,287 482.0200 NSE
10 Dec 2024 BIOCON LIMITED Bulk Sell 8,000,000 857.6800 BSE
1 Feb 2023 FRST SNTR INVTS GLBL UMBRELLA FD PLC-STEWART INVTS INDN SUBCONT SUSTABLE FD Block Buy 1,250 560.0000 BSE
1 Feb 2023 KOTAK INFINITY FUND Block Buy 1,300 560.0000 BSE
1 Feb 2023 MATTHEWS ASIA FUNDS INDIA FUND Block Buy 10,412 560.0000 BSE
1 Feb 2023 INDIA ACORN ICAV ASHOKA INDIA ESG FUND Block Buy 13,000 560.0000 BSE
1 Feb 2023 EDELWEISS MUTUAL FUND Block Buy 19,137 560.0000 BSE
1 Feb 2023 CFSIL - COLONIAL FIRST STATE GLOBAL ASSET MANAGEMENT EQUITY TRUST 3 Block Buy 19,972 560.0000 BSE
1 Feb 2023 FS INV ICVC STEWART INVESTORS GLOBAL EMERGING MARKETS FUND Block Buy 20,831 560.0000 BSE

All bulk and block deals →

Dividends

Full dividend history →
Last 12 months ₹1.25 per share
Dividend yield 0.34%
Ex-dateSubjectPer share (₹)Record date
25 Jun 2026 Dividend - Rs 1.25 Per Share 1.2500 26 Jun 2026
27 Jun 2025 Dividend - Rs 1.25 Per Share 1.2500 27 Jun 2025
28 Jun 2024 Dividend - Rs 1.25 Per Share 1.2500 28 Jun 2024
30 Jun 2023 Dividend - Rs 0.50 Per Share/Special Dividend - Rs 0.75 Per Share 0.5000 30 Jun 2023
30 Jun 2022 Dividend - Rs 0.50 Per Share/Special Dividend - Rs 0.50 Per Share 0.5000 1 Jul 2022
16 Jul 2019 Dividend - Rs 0.50 Per Share 0.5000 17 Jul 2019
17 Jul 2018 Dividend Re - Re 1 Per Share 1.0000 18 Jul 2018
20 Jul 2017 Dividend - Rs 1/- Per Share 1.0000 21 Jul 2017
17 Mar 2016 Interim Dividend - Re 1/- Per Share (Purpose Revised) 1.0000 19 Mar 2016

Corporate Actions

Full history (11 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
11 Jun 2019BONUS Bonus 1:1
13 Jul 2021OTHER Annual General Meeting

All corporate actions →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
29 Jul 2026 Financial Results Yes
29 Apr 2026 Financial Results/Dividend Yes
22 Jan 2026 Financial Results Yes
5 Nov 2025 Financial Results Yes
23 Jul 2025 Financial Results Yes

Corporate Announcements

All 1039 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
25 Sep 2026 Trading Window Syngene International Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
25 Sep 2026 Insider Trading / SAST Syngene International Ltd - 539268 - Closure of Trading Window
24 Sep 2026 General Updates Syngene International Limited has informed the Exchange about Intimation of cancellation of meeting with Analyst/Institutional Investors
21 Sep 2026 Resignation of Director/KMP/SMP Syngene International Limited has informed the Exchange about Resignation of Director/KMP/SMP
21 Sep 2026 Resignation Syngene International Limited has informed the Exchange regarding Resignation of Mr. Pramuch Goel as Head Corporate Affairs & Communications and a member of Executive Committee (Senior Management Personnel) of the company w.e.f. close of business hours of September 21, 2026.
21 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Syngene International Limited has informed the Exchange about Schedule of meet
21 Sep 2026 Company Update Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12 Sep 2026 Company Update Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Syngene International Limited has informed the Exchange about Schedule of meet
11 Sep 2026 Company Update Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (13.4x)

Weaknesses

  • Low Return on Equity (6.5%)
  • Declining revenue YoY (-17.1%)
  • Declining profit YoY (-15.0%)

Opportunities

Data unavailable.

Threats

  • PE above 35 (64.2) -- priced for continued strong execution
  • Down 42.2% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Single-stock futures available for this stock -- OI buildup, PCR, Max Pain and Greeks are all on the full F&O page.

Part of: NIFTY 500, NIFTY 500

Frequently asked questions about Syngene International Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.